Details of the Drug Formulaction

General Information of Drug Formulation (ID: F24370)

Formulation Name
Lorlatinib 25 mg tablet
Company
Pfizer Laboratories Div Pfizer
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Lorlatinib DMICDLV Non-small-cell lung cancer 2C25.Y Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Calcium hydrogenphosphate E00294 24441 Diluent
Cellulose microcrystalline E00698 Not Available Adsorbent; Suspending agent; Diluent
Ferrosoferric oxide E00231 14789 Colorant
Haematite red E00236 14833 Colorant
Hypromellose E00634 Not Available Coating agent
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Polyethylene glycol 3350 E00652 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Triacetin E00080 5541 Humectant; Plasticizing agent; Solvent